Lakefront Biotherapeutics - American Depositary Shares (LKFT)
NASDAQ · Healthcare
$29.02-3.30%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.98B
- P/E ratio
- —
- EPS
- —
- Volume
- 155,889
- 52-week high
- —
- 52-week low
- —
- Open
- $30.02
- Day high
- $30.25
- Day low
- $28.98
Financial highlights
Annual financials for Lakefront Biotherapeutics - American Depositary Shares are being compiled and will appear here soon.
About Lakefront Biotherapeutics - American Depositary Shares
Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics. Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis. The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es, and maintains its headquarters in Mechelen, Belgium.
- CEO
- Henry O. Gosebruch
- Employees
- 452
- Country
- BE
- IPO date
- May 5, 2005
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Lakefront Biotherapeutics - American Depositary Shares's stock price today?
- LKFT is trading at $29.02 as of Jul 20, 2026.
- What is Lakefront Biotherapeutics - American Depositary Shares's market cap?
- Lakefront Biotherapeutics - American Depositary Shares (LKFT) has a market capitalization of $1.98B.
- What sector is Lakefront Biotherapeutics - American Depositary Shares in?
- Lakefront Biotherapeutics - American Depositary Shares operates in the Healthcare sector.